These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3732311)

  • 41. The effect of blood transfusion on 51Cr-red blood cells surface-counting data in homozygous beta-thalassaemia.
    Dimitriou PA; Germenis AE; Kasfiki AG; Depasquale AK; Karpathios TE; Antipas SE
    Clin Lab Haematol; 1991; 13(4):363-70. PubMed ID: 1773590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-thalassaemia--the Johannesburg experience.
    Poole JE; Cohn RJ; Roode H; Spector I
    S Afr Med J; 1989 Apr; 75(8):367-70. PubMed ID: 2652340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between red cell pyruvate kinase activity and haematological parameters.
    el-Hazmi MA; Warsy AS
    Med Lab Sci; 1990 Apr; 47(2):80-4. PubMed ID: 2381272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test.
    Kickler TS; Smith B; Bell W; Drew H; Baldwin M; Ness PM
    Transfusion; 1985; 25(5):401-5. PubMed ID: 4049483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
    Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
    Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.
    Caram-Deelder C; Kreuger AL; Evers D; de Vooght KMK; van de Kerkhof D; Visser O; Péquériaux NCV; Hudig F; Zwaginga JJ; van der Bom JG; Middelburg RA
    JAMA; 2017 Oct; 318(15):1471-1478. PubMed ID: 29049654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Red cell transfusion in paediatric patients with thalassaemia and sickle cell disease: Current status, challenges and perspectives.
    Tzounakas VL; Valsami SI; Kriebardis AG; Papassideri IS; Seghatchian J; Antonelou MH
    Transfus Apher Sci; 2018 Jun; 57(3):347-357. PubMed ID: 29880248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.
    Taher AT; Radwan A; Viprakasit V
    Vox Sang; 2015 Jan; 108(1):1-10. PubMed ID: 25286743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood transfusion in beta thalassaemia major.
    Rebulla P
    Transfus Med; 1995 Dec; 5(4):247-58. PubMed ID: 8646287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Red blood cell metabolism and function in transfused beta-thalassemia.
    de Furia FG; Miller DR; Canale VC
    Ann N Y Acad Sci; 1974; 232(0):323-32. PubMed ID: 4278245
    [No Abstract]   [Full Text] [Related]  

  • 52. Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: a new perspective on Cooley's anemia therapy.
    Ropars C; Teisseire B; Avenard G; Chassaigne M; Hurel C; Girot R; Nicolau C
    Ann N Y Acad Sci; 1985; 445():304-15. PubMed ID: 3860134
    [No Abstract]   [Full Text] [Related]  

  • 53. Current therapy and new approaches to the treatment of thalassemia major.
    Wolfe L; Sallan D; Nathan DG
    Ann N Y Acad Sci; 1985; 445():248-55. PubMed ID: 3860127
    [No Abstract]   [Full Text] [Related]  

  • 54. Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry.
    Khuhapinant A; Bunyaratvej A; Tatsumi N; Pribwai M; Fucharoen S
    Acta Haematol; 1994; 91(3):119-25. PubMed ID: 8091932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.
    Aydinok Y; Piga A; Origa R; Mufti N; Erickson A; North A; Waldhaus K; Ernst C; Lin JS; Huang N; Benjamin RJ; Corash L
    Br J Haematol; 2019 Aug; 186(4):625-636. PubMed ID: 31148155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfusional profile in different types of intensive care units.
    de Paula IC; Azevedo LC; Falcão LF; Mazza BF; Barros MM; Freitas FG; Machado FR
    Braz J Anesthesiol; 2014; 64(3):183-9. PubMed ID: 24907878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal.
    Egberts J; van Kamp IL; Kanhai HH; Meerman RH; Giordano PC; Gravenhorst JB
    Br J Obstet Gynaecol; 1997 Jul; 104(7):818-24. PubMed ID: 9236647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current recommendations for chelation for transfusion-dependent thalassemia.
    Kwiatkowski JL
    Ann N Y Acad Sci; 2016 Mar; 1368(1):107-14. PubMed ID: 27186943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.